AI Revolutionizing Cardiovascular Drugs Manufacturing 2025

Cardiovascular diseases (CVDs) remain a formidable global health challenge, making the cardiovascular drugs market a critical and ever-evolving sector. In 2025, this market is not just responding to existing needs but is actively being shaped by groundbreaking scientific advancements, technological integration, and a sharpened focus on patient-cent

read more